Clinical Trial Update: Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Homoharringtonine for chronic myeloid leukemia, including chronic-phase and pediatric cases, with study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Homoharringtonine (homoharringtonine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | Status: COMPLETED